Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Cilostazol and primary-PCI: mirage or good alternative?

Porto I, D'Amario D, Crea F. Cilostazol and primary-PCI: mirage or good alternative? Curr Vasc Pharmacol. 2012 Jul; 10(4):468-71.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.